Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

doctor comparing the costs of different medical treatments

AI assistance could cut screening-related costs by up to 30%

Integrating AI-based delegation tools into breast cancer screening settings could result in significant cost savings for organizations.

Thumbnail

Incidental findings evident in 70% of lung screening exams, but few reported

Despite this, consensus is lacking on whether radiologists should be required to report on findings that are not relevant to the exam. 

cancer screening puzzle

How tax policies impact cancer mortality rates

According to a new analysis, the relationship between the two is actually quite significant. 

radiation oncology therapy treatment

New data question the role radiation therapy plays in cardiovascular health

There has been back-and-forth among experts on the relationship between breast arterial calcifications and cardiovascular disease for many years.

lung cancer screening

AI is most beneficial as a prescreening tool, new research suggests

Researchers deployed AI in multiple interpretation scenarios to assess how it might impact radiologists’ performances. 

Opportunistic screening tool for osteoporosis nabs FDA clearance

The algorithm can be applied to noncontrast abdominal CT scans completed for any clinical indication.

doctor wrong patient wrong-site surgery medical error malpractice mistake

Not all radiologists are buying what AI is selling, even when the technology outperforms humans

Providers are up to three times more likely to trust the opinion of humans over AI, even when the algorithm is proven to detect more cancerous lesions than radiologists. 

Interval breast cancer rates on the rise.

Rising rates of interval breast cancers have experts calling for more risk-based screenings

A new analysis suggests interval cancer rates among women with a prior history of breast cancer may be as high as 30%.